secwatch.observer — SEC 8-K summary
======================================

Issuer:     MPLX LP (MPLX)
CIK:        0001552000
Form:       8-K
Filed at:   2022-04-21T23:59:59+00:00
Accession:  0001552000-22-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MPLX CEO Michael Hennigan discloses throat cancer diagnosis; says prognosis is curable
--------------------------------------------------------------------------------

- CEO diagnosed with throat cancer, caught early and considered curable per leading medical institutions.
- Will undergo seven-week radiation and chemotherapy treatment while continuing as CEO with limited travel.
- Board fully apprised and supportive; no leadership change announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552000/000155200022000011/0001552000-22-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552000/000155200022000011/mplx-20220421.htm
  HTML page:      https://secwatch.observer/filing/0001552000-22-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer